CNC Centene Corp
Company Analysis
Latest News
🟢 Centene is trading 4% up today as healthcare-sector sentiment strengthens on medical-device earnings
Centene is trading 4.02% up at $67.85 as healthcare-sector sentiment strengthened on positive medical-device earnings and a going-private proposal for...
🔴 Centene is trading 4.12% down today after announcing CFO succession
Centene is trading 4.12% down at $64.69 after CFO Andrew Asher’s December 2026 step-down and end-2027 retirement announcement. - Christopher Neczypor,...
Centene Announces CFO Transition and Reaffirms Full-Year 2026 EPS Guidance
Centene Corporation announced that Chief Financial Officer Andrew Asher will retire at the end of 2026, with Christopher Neczypor, former CFO of Lincoln...
🔴 Centene is trading 4.02% down today amid possible enrollment and cost concerns
Centene is trading at $64.30, with a -4.02% change as investors may be reassessing enrollment and cost concerns. - The decline reverses part of the 4.56% gain...
🟢 Centene is trading 4.3% up today as robust earnings and raised guidance fuel a multi-day rally
Centene is trading 4.3% up today at $66.85, extending a multi-day rally driven by robust recent earnings and raised guidance that bolstered investor...
Centene Faces Surging Churn Risk, Following End of Medicare Part D Subsidies
Centene faces a significant risk of customer churn in its standalone Medicare Part D prescription drug plans. This follows the federal government’s decision to...
🔴 Centene is trading 6.8% down today as post-earnings gains evaporate
Centene is trading 6.8% down now at $59.74 after a strong Q2 earnings report failed to hold initial gains. • The company beat estimates and raised full-year...
Centene Crushes Q2 Estimates and Raises Its Outlook — So Why Are Investors Heading for the Exits?
Shares shifted sharply as Centene Corp. dropped 9.1% in pre-market trading to $58.23 despite delivering a blowout second quarter this morning. The paradox — a...
🔴 Centene is trading 9.1% down today despite Q2 beat and raised guidance
Centene is trading 9.1% down at $58.23 as investors reassess the company's margin trajectory and updated guidance following its Q2 2026 earnings report. • The...
Centene's second quarter 2026 earnings crushed estimates, leading to a raised full-year outlook.
Centene reported second quarter 2026 total revenues of $53.6 billion and GAAP EPS of $2.19, significantly exceeding analyst expectations. The company's Health...
Centene Corp Q2 2026 Earnings Preview: What Analysts Expect on July 28, 2026
Centene Corporation is expected to report Q2 2026 revenue of $47.53 billion and earnings per share of $0.89, with its current price of $63.35 trading slightly...
Centene Shares Sink, Pressured by $1 Billion Medicaid Payment Freeze
Centene shares fell sharply on July 23, 2026, following new regulatory challenges to its Medicaid business. The Centers for Medicare & Medicaid Services...
Centene awards Cognizant $1 billion contract to automate healthcare operations
Centene Corp awarded a multi-year technology services contract to Cognizant. The deal is valued at more than $500 million and could potentially reach $1...
🟢 Centene is trading 4% up today as UnitedHealth results lift healthcare sector
Centene is trading 4% up at $66.45, rebounding from recent weakness as strong UnitedHealth earnings boost sentiment across the managed care space. • The stock...
Centene faces membership risk, as new law doubles Medicaid eligibility checks
A 2025 federal law will require states to verify Medicaid eligibility every six months. This mandate doubles the current annual frequency for adults aged 19-64...
🟢 Centene Surges 4.6% in Pre-Market on Analyst Upgrades and Strong Q1 2026 Performance
Centene is trading 4.6% up at $69.69 in pre-market, driven by recent analyst upgrades and a strong Q1 2026 earnings beat. The stock is rebounding after a sharp...
🔴 Centene is trading 7.8% down today on Medicaid cost pressure and sector-wide weakness
Centene is trading at $63.35 (-7.81%) as investors react to ongoing Medicaid cost pressure and broader healthcare-sector weakness. • The company remains under...
🔴 Centene is trading 4.4% down today on Medicaid cost concerns and geopolitical stress
Centene is trading at $65.72 (4.4% down) as Medicaid cost concerns and geopolitical stress weigh on the healthcare sector. • The decline extends recent...
Centene Secures Illinois Medicaid Renewal to Serve 596,000 Members
Centene Corporation’s subsidiary, Meridian Health Plan, secured a new four-year contract from the Illinois Department of Healthcare and Family Services. The...
Centene Mentioned in Sector-Wide Coverage of Rising Obamacare Premiums
Industry reports indicate potential significant increases in Obamacare premiums for 2027, impacting Centene Corporation. Insurers forecast rate hikes, with...